Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
18.48
-0.36 (-1.91%)
Aug 29, 2025, 4:00 PM - Market closed

Neurogene Statistics

Total Valuation

Neurogene has a market cap or net worth of $263.75 million. The enterprise value is $192,008.

Market Cap263.75M
Enterprise Value 192,008

Important Dates

The last earnings date was Monday, August 11, 2025, after market close.

Earnings Date Aug 11, 2025
Ex-Dividend Date n/a

Share Statistics

Neurogene has 14.27 million shares outstanding. The number of shares has increased by 52.10% in one year.

Current Share Class 14.27M
Shares Outstanding 14.27M
Shares Change (YoY) +52.10%
Shares Change (QoQ) +0.28%
Owned by Insiders (%) 10.91%
Owned by Institutions (%) 53.15%
Float 4.80M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.97
P/TBV Ratio 0.97
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.07, with a Debt / Equity ratio of 0.04.

Current Ratio 18.07
Quick Ratio 17.86
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11,961.50

Financial Efficiency

Return on equity (ROE) is -39.41% and return on invested capital (ROIC) is -26.40%.

Return on Equity (ROE) -39.41%
Return on Assets (ROA) -25.07%
Return on Invested Capital (ROIC) -26.40%
Return on Capital Employed (ROCE) -33.95%
Revenue Per Employee n/a
Profits Per Employee -$788,729
Employee Count107
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -48.31% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -48.31%
50-Day Moving Average 20.34
200-Day Moving Average 19.06
Relative Strength Index (RSI) 35.93
Average Volume (20 Days) 110,104

Short Selling Information

The latest short interest is 2.66 million, so 18.63% of the outstanding shares have been sold short.

Short Interest 2.66M
Short Previous Month 2.59M
Short % of Shares Out 18.63%
Short % of Float 55.40%
Short Ratio (days to cover) 21.71

Income Statement

Revenue n/a
Gross Profit -68.76M
Operating Income -95.69M
Pretax Income -55.44M
Net Income -84.39M
EBITDA -92.56M
EBIT -95.69M
Earnings Per Share (EPS) -$4.30
Full Income Statement

Balance Sheet

The company has $274.52 million in cash and $10.97 million in debt, giving a net cash position of $263.55 million or $18.47 per share.

Cash & Cash Equivalents 274.52M
Total Debt 10.97M
Net Cash 263.55M
Net Cash Per Share $18.47
Equity (Book Value) 273.26M
Book Value Per Share 19.15
Working Capital 263.55M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.30 million and capital expenditures -$1.21 million, giving a free cash flow of -$74.51 million.

Operating Cash Flow -73.30M
Capital Expenditures -1.21M
Free Cash Flow -74.51M
FCF Per Share -$5.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Neurogene does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -52.10%
Shareholder Yield -52.10%
Earnings Yield -32.00%
FCF Yield -28.25%

Analyst Forecast

The average price target for Neurogene is $41.86, which is 126.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target $41.86
Price Target Difference 126.52%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 132.79%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Neurogene has an Altman Z-Score of 8.01 and a Piotroski F-Score of 2.

Altman Z-Score 8.01
Piotroski F-Score 2